Aoxing Pharmaceutical Company, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2016. For the quarter, the company reported sales of $8,009,111 against $8,195,839 a year ago. Income from operations was $233,196 against $3,410,023 a year ago. Loss before income taxes was $389,857 against income of $2,597,661 a year ago. Loss attributable to shareholders of the company was $43,453 or $0.00 per basic and diluted share against income of $2,068,635 or $0.03 per basic and diluted share a year ago. For the six months, the company reported sales of $15,578,407 against $16,940,661 a year ago. Income from operations was $1,936,702 against $6,549,225 a year ago. Income before income taxes was $652,977 against $4,889,897 a year ago. Income attributable to shareholders of the company was $302,627 or $0.00 per basic and diluted share against $3,336,571 or $0.05 per basic and diluted share a year ago.